[go: up one dir, main page]

AU2002349773A1 - 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof - Google Patents

4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof

Info

Publication number
AU2002349773A1
AU2002349773A1 AU2002349773A AU2002349773A AU2002349773A1 AU 2002349773 A1 AU2002349773 A1 AU 2002349773A1 AU 2002349773 A AU2002349773 A AU 2002349773A AU 2002349773 A AU2002349773 A AU 2002349773A AU 2002349773 A1 AU2002349773 A1 AU 2002349773A1
Authority
AU
Australia
Prior art keywords
difluoro
tetrahydro
salts
benzazepine derivatives
benzazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002349773A
Other versions
AU2002349773B2 (en
Inventor
Seijiro Akamatsu
Hiroyuki Koshio
Takahiro Kuramochi
Chikashi Saitoh
Issei Tsukamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority claimed from PCT/JP2002/011842 external-priority patent/WO2003042181A1/en
Publication of AU2002349773A1 publication Critical patent/AU2002349773A1/en
Assigned to ASTELLAS PHARMA INC. reassignment ASTELLAS PHARMA INC. Request for Assignment Assignors: YAMANOUCHI PHARMACEUTICALS CO., LTD.
Application granted granted Critical
Publication of AU2002349773B2 publication Critical patent/AU2002349773B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002349773A 2001-11-16 2002-11-13 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof Ceased AU2002349773B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-350909 2001-11-16
JP2001350909 2001-11-16
JP2002252931 2002-08-30
JP2002-252931 2002-08-30
PCT/JP2002/011842 WO2003042181A1 (en) 2001-11-16 2002-11-13 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivatives or salts thereof

Publications (2)

Publication Number Publication Date
AU2002349773A1 true AU2002349773A1 (en) 2003-07-24
AU2002349773B2 AU2002349773B2 (en) 2007-12-13

Family

ID=26624548

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349773A Ceased AU2002349773B2 (en) 2001-11-16 2002-11-13 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof

Country Status (17)

Country Link
US (1) US7169772B2 (en)
EP (1) EP1445253B1 (en)
JP (1) JP4075064B2 (en)
KR (1) KR100632882B1 (en)
CN (1) CN1323076C (en)
AT (1) ATE438626T1 (en)
AU (1) AU2002349773B2 (en)
BR (1) BR0214224A (en)
CA (1) CA2464069A1 (en)
DE (1) DE60233251D1 (en)
ES (1) ES2327620T3 (en)
HU (1) HUP0402235A2 (en)
MX (1) MXPA04004501A (en)
NO (1) NO20042497L (en)
PL (1) PL369999A1 (en)
RU (1) RU2268882C1 (en)
WO (1) WO2003042181A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ATE513838T1 (en) 2002-09-20 2011-07-15 Promega Corp LUMINESCENCE-BASED METHODS AND PROBE FOR MEASUREMENT OF CYTOCHROME P450 ACTIVITY
AU2003294275A1 (en) * 2002-11-21 2004-06-18 New York Blood Center Compounds for inhibition of hiv infection by blocking hiv entry
RU2326868C2 (en) 2003-04-28 2008-06-20 Астеллас Фарма Инк. Derivative of 4,4-difluoro-1,2,2,4-tetrahydro-5h-1-benzazepine and its salt
US8519158B2 (en) * 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
EP1935986B1 (en) 2005-05-31 2014-04-16 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
WO2006130551A2 (en) 2005-05-31 2006-12-07 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
CA2616079C (en) 2005-07-22 2012-09-25 Mochida Pharmaceutical Co., Ltd. Novel heterocyclidene acetamide derivative
JP5164510B2 (en) * 2006-10-06 2013-03-21 日本曹達株式会社 Nitrogen-containing heterocyclic compounds and pest control agents
EP2119719A1 (en) 2006-12-26 2009-11-18 Daiichi Sankyo Company, Limited Thiazepine derivative
US20100016285A1 (en) * 2007-01-24 2010-01-21 Mochida Pharmaceutical Co., Ltd. Heterocyclidene-n-(aryl) acetamide derivative
PE20081692A1 (en) 2007-01-24 2008-12-18 Mochida Pharm Co Ltd NEW DERIVATIVE OF HETEROCICLIDEN ACETAMIDA
RU2515968C2 (en) * 2007-04-11 2014-05-20 Киссеи Фармасьютикал Ко., Лтд. 5-membered heterocyclic compound and its application for medicinal purposes
CA2695634C (en) 2007-08-06 2018-01-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
EP3225249B1 (en) * 2008-05-21 2018-11-07 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
UY32940A (en) 2009-10-27 2011-05-31 Bayer Cropscience Ag AMIDAS REPLACED WITH HALOGENO RENT AS INSECTICIDES AND ACARICIDES
JPWO2013187406A1 (en) 2012-06-11 2016-02-04 アステラス製薬株式会社 Process for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound and synthetic intermediate thereof
RU2642783C2 (en) * 2012-12-26 2018-01-26 Санва Кагаку Кенкюсо Ко., Лтд. New benzoazepine derivative and its medical application
JP6703484B2 (en) 2014-01-29 2020-06-03 プロメガ コーポレイションPromega Corporation Quinone-masked probe as a labeling reagent for cellular uptake measurements
CN105310978A (en) * 2014-08-04 2016-02-10 李峰 Drug combination containing conivaptan hydrochloride as active ingredient and preparation of drug combination
BR112021020864A2 (en) 2019-04-19 2021-12-14 Ligand Pharm Inc Crystalline forms and methods of producing crystalline forms of a compound
CN112079826B (en) * 2020-09-17 2022-07-29 广州中医药大学(广州中医药研究院) Steroid synthetase inhibitor and treatment application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1039999A (en) * 1988-07-30 1990-02-28 刘晓非 Multiple layer decorative compound sheet and preparation method
TW270927B (en) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
WO1995006035A1 (en) 1993-08-26 1995-03-02 Yamanouchi Pharmaceutical Co., Ltd. Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
TW359669B (en) 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
JPH09221475A (en) 1996-02-13 1997-08-26 Yamanouchi Pharmaceut Co Ltd Novel oxime derivative
AR011913A1 (en) 1997-03-06 2000-09-13 Yamano Masaki DERIVATIVES OF 4,4-DIFLUORO-2,3,4,5-TETRAHIDRO-1H-1-BENZOAZEPINA AND PHARMACEUTICAL COMPOSITIONS THEREOF.

Similar Documents

Publication Publication Date Title
AU2002349773A1 (en) 4,4-Difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine derivatives or salts thereof
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
EP1416935B8 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU2002349676A1 (en) 4-oxoquinoline derivatives
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2002349777A1 (en) Novel benzophenone derivatives or salts thereof
AU2002352444A1 (en) Quinazolinedione derivatives
MXPA03008140A (en) Substituted benzofuran-2-carboxamides derivatives.
AU2001289937A1 (en) Substituted 1-aminobutan-3-ol derivatives
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2002214975A1 (en) Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
AU2002212263A1 (en) Substituted 5-amino-1-pentene-3-ol derivatives
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2001256791A1 (en) 5,6-trans-2-alkylvitamin d derivatives
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
AU2003224149A1 (en) N'-cyano-n-methyl-imidamide derivatives
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
AU2003255737A1 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
AU2001248330A1 (en) Substituted 1-aryl-cyclopropylmethylamino-1,3,5-triazines
AU2002251501A1 (en) 2-iminoimidazole derivatives (1)
AU2001288637A1 (en) 1,2-oxazin-3-one derivatives as antibacterial agents
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002247745B2 (en) Pharmaceutical salts